Login
Cart
Support
Search
Search
Search
Kevin Shan
Appearances
View Grid
ETRASIMOD FOR THE TREATMENT OF ULCERATIVE COLITIS: UP TO 2.5 YEARS OF POOLED SAFETY DATA FROM GLOBAL CLINICAL TRIALS
Date
May 9, 2023
BACKGROUND AND AIMS: A treat-to-target (TTT) strategy of striving for symptomatic and endoscopic remission is recommended for the management of inflammatory bowel diseases (IBD). Yet, real-world uptake of TTT strategies has been modest…
Presenter
Séverine Vermeire
Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven
Speakers
Laurent Peyrin-Biroulet
Julián Panés
Miguel Regueiro
Cleveland Clinic
Paulo Kotze
Aline Charabaty
Martina Goetsch
Kevin Shan
Joseph Wu
Aoibhinn McDonnell
John Woolcott
Silvio Danese